WTW

Quick Report on Willis Towers Watson Public (WTW)

Today we're going to take a closer look at large-cap Finance company Willis Towers Watson Public, whose shares are currently trading at $234.51. We've been asking ourselves whether the company is under or over valued at today's prices... let's perform a brief value analysis to find out!

Willis Towers Watson Public's Valuation Is in Line With Its Sector Averages:

Willis Towers Watson Public Limited Company operates as an advisory, broking, and solutions company worldwide. The company belongs to the Finance sector, which has an average price to earnings (P/E) ratio of 14.34 and an average price to book (P/B) ratio of 1.57. In contrast, Willis Towers Watson Public has a trailing 12 month P/E ratio of 22.8 and a P/B ratio of 2.47.

When we divide Willis Towers Watson Public's P/E ratio by its expected five-year EPS growth rate, we obtain a PEG ratio of 0.98, which indicates that the market is undervaluing the company's projected growth (a PEG ratio of 1 indicates a fairly valued company). Your analysis of the stock shouldn't end here. Rather, a good PEG ratio should alert you that it may be worthwhile to take a closer look at the stock.

EPS Trend Sustained Primarily by Reducing the Number of Shares Outstanding:

2019-12-31 2020-12-31 2021-12-31 2022-12-31
Revenue (MM) $9,039 $9,352 $8,998 $8,866
Interest Income (MM) -$234 -$244 -$211 -$208
Operating Margins 14.7% 12.9% 24.8% 14.4%
Net Margins 11.55% 10.65% 46.92% 11.38%
Net Income (MM) $1,044 $996 $4,222 $1,009
Depreciation & Amort. (MM) -$729 -$770 -$650 -$567
Earnings Per Share $8.02 $7.65 $32.78 $10.29
EPS Growth n/a -4.61% 328.5% -68.61%
Diluted Shares (MM) 130 130 129 106
Free Cash Flow (MM) $776 $1,488 $1,860 $608
Capital Expenditures (MM) -$305 -$286 -$201 -$204
Net Current Assets (MM) -$8,020 -$7,298 -$3,174 -$5,841
Current Ratio 1.06 1.05 1.26 1.07
Long Term Debt (MM) $5,301 $4,664 $3,974 $4,471
Net Debt / EBITDA 2.17 1.59 0.01 1.81
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS